Emerging National Trends in Normothermic Regional Perfusion for Simultaneous Pancreas–Kidney Transplantation
Clinical Transplantation · 2025-11 · 39 (11)
DOI: 10.1111/ctr.70389 ↗At a glance
Journal article in Clinical Transplantation, published online on 2025-11-19. Written by Raphaël M J Fischer and 5 co-authors. Institution: Department of Surgery, Erasmus Medical Center, Erasmus University Rotterdam, Rotterdam, the Netherlands. Major MEDLINE topics: Pancreas Transplantation, Kidney Transplantation, Perfusion, Tissue and Organ Procurement. Cited 6 times so far (Crossref); 20 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Background
Normothermic regional perfusion (NRP) is rapidly gaining adoption for donation after cardiac death (DCD) organ recovery in the United States. However, little is known about trends in NRP procured grafts for simultaneous pancreas–kidney transplantation (SPK).
Design
SPK recipients between January 2021 and June 2025 were identified using the United Network for Organ Sharing (UNOS)/Organ Procurement and Transplantation Network (OPTN) national data. Patients DCD‐SPK donors and recipients were included and grouped by recovery method.
Measurements
Donor and recipient demographic data were described. Primary outcomes were pancreas and kidney graft survival at 1 year, evaluated with Kaplan–Meier survival curves. Kidney outcomes included delayed graft function and creatinine levels.
Results
A total of 137 DCD SPKs were included, with NRP and super‐rapid recovery (SRR) performed in 33 (24%) and 104 (76%) of donors, respectively. Donors in the NRP group were older (28 [22–34] vs. 22 [18–29], p < 0.05) and had a longer withdrawal‐to‐death time (22 [18–24] vs. 18 [15–22], p < 0.05). Recipients in the NRP group were younger (38 [35–46] vs. 48 [39‐55], p < 0.05), more frequently transplanted for Type 1 diabetes, and had worse functional status at the time of transplant. NRP was associated with lower rates of delayed kidney graft function (6% vs. 33%, p < 0.05) and a trend toward lower 6‐month creatinine (1.1 vs. 1.3 mg/dL, p = 0.054), with similar 1‐year values. One‐year pancreas and kidney graft survival following NRP were 91% and 100%, respectively.
Conclusions
Since the introduction of NRP, 24% of the DCD‐SPK grafts were procured with NRP. Comparable 1‐year kidney and pancreas graft survival between SRR and NRP with lower rates of kidney dysfunction following NRP.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Surgery, Erasmus Medical Center, Erasmus University Rotterdam, Rotterdam, the Netherlands.
- Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Department of Nephrology SUNY Downstate Medical Center Brooklyn, New York, USA.
ORCID profiles: Raphaël M J Fischer, Angelika C Gruessner
Cite
APA
Fischer, R. M. J., Muñoz, N., Ong, O., L Abt, P., C Gruessner, A., & F Parsons, R. (2025). Emerging National Trends in Normothermic Regional Perfusion for Simultaneous Pancreas–Kidney Transplantation. Clinical Transplantation, 39(11). https://doi.org/10.1111/ctr.70389
Vancouver
Fischer RMJ, Muñoz N, Ong O, L Abt P, C Gruessner A, F Parsons R. Emerging National Trends in Normothermic Regional Perfusion for Simultaneous Pancreas–Kidney Transplantation. Clinical Transplantation. 2025;39(11). doi:10.1111/ctr.70389
BibTeX
@article{Fischer2025,
author = {Fischer, Raphaël M J and Muñoz, Nicolas and Ong, Olivia and L Abt, Peter and C Gruessner, Angelika and F Parsons, Ronald},
title = {Emerging National Trends in Normothermic Regional Perfusion for Simultaneous Pancreas–Kidney Transplantation},
journal = {Clinical Transplantation},
year = {2025},
volume = {39},
number = {11},
doi = {10.1111/ctr.70389}
}
EUVIMED